ROUTT, E. Long Term Outcomes for Basal Cell Carcinoma Treated with Vismodegib Extended Alternate Day Dosing. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 3, n. 2, p. 150–151, 2019. DOI: 10.25251/skin.3.2.32. Disponível em: https://jofskin.org/index.php/skin/article/view/587. Acesso em: 3 jul. 2024.